Canaccord Genuity analyst Neil Maruoka came out today with a research note on Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), after the company released its fourth-quarter results, posting a net loss …
By Sarah Roden Valeant Pharmaceuticals (NYSE:VRX) beat out Endo International in a battle to take over Salix Pharmaceuticals (NASDAQ:SLXP) in a deal valued …
In a research report issued on March 16, Canaccord Genuity analyst Neil Maruoka maintained a Buy rating on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) received another set of praises today from analyst Neil Maruoka of Canaccord Genuity in a research report released today. The report comes …
In a research report released today, Canaccord Genuity analyst Neil Maruoka reiterated a Buy rating on Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) with a C$2.
In a research report issued today, Canaccord Genuity analyst Neil Maruoka maintained a Buy rating on Valeant Pharmaceuticals (NYSE:VRX) with a price target of …
In a research note issued today, Canaccord maintained coverage with a “Buy” rating on Valeant Pharmaceuticals (VRX), and a price target of $168.00 a share.
